Found 12 matching trials
Biosimilar Study Comparing PK, PD, Safety and Immunogencity of BP11 With US Licensed Xolair and EU Approved Xolair
PHASE1A single dose, double blind comparative trial to assess the pharmacokinetic...
Comparison of Pharmacokinetics and Safety of HS632 and Xolair® With a Single Injection
PHASE1To evaluate the bioequivalence of HS632 and Omalizumab (Xolair®) in a singl...
Cold Urticaria Treatment With Xolair
PHASE2Urticaria is a very frequent skin condition characterised by transient whea...
Location
University Aachen
Urticaria Facticia Treatment With Omalizumab (UFO)
PHASE2Urticaria is a very frequent skin condition characterized by transient whea...
Location
University Dermatology Freiburg
Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria
PHASE3The purpose of this study was to demonstrate the efficacy and safety of oma...
Location
Novartis Investigative Site
A Comparative Pharmacokinetic Study of ADL-018 Autoinjector Compared to A Pre-filled Syringe in Healthy Subjects.
PHASE1The Goal of these study is to assess the comparative pharmacokinetics of Te...
Location
Cliantha Research
Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps
N/AThis study aims to evaluate the safety and effectiveness of Xolair® in pati...
Location
Novartis Investigative Site
The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD and Safety
PHASE1A phase 1, randomized, double-blind, parallel group, single-dose study to c...
Location
Shanghai Xuhui Central Hospital
OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients
PHASE3This trial assessed the efficacy of optimized re-treatment therapy with oma...
Location
Novartis Investigative Site
Treatment of Idiopathic Angioedema With Xolair as Add-on Therapy
PHASE4The overall hospitalizations for a diagnosis of angioedema doubled from the...